Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1994 Nov;62(11):4893–4899. doi: 10.1128/iai.62.11.4893-4899.1994

The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation.

D L Tolson 1, A Jardim 1, L F Schnur 1, C Stebeck 1, C Tuckey 1, R P Beecroft 1, H S Teh 1, R W Olafson 1, T W Pearson 1
PMCID: PMC303204  PMID: 7927770

Abstract

Kinetoplastid membrane protein 11 (KMP-11) from Leishmania donovani is an abundant 11-kDa surface membrane glycoprotein. Lymph node cells from mice of six different H-2 haplotypes immunized with KMP-11 or with L. donovani promastigotes were stimulated to proliferate in vitro KMP-11. Primed purified T cells required antigen presentation since they were not stimulated unless KMP-11-pulsed or L. donovani-infected macrophages were added. Promastigotes of a wide variety of Leishmania species and procyclic forms of African trypanosomes stimulated proliferation of KMP-11-primed or L. donovani promastigote-primed lymph node cells. All of the Leishmania promastigotes and African trypanosomes tested contained an 11-kDa protein, as detected by immunoblotting with KMP-11-specific monoclonal antibodies. The widespread distribution of the 11-kDa (KMP-11) molecules and their ability to stimulate strong T-lymphocyte proliferation in a non-H-restricted fashion suggest that they may be important molecules for induction of cell-mediated immune responses.

Full text

PDF
4893

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAER H., CHAPARAS S. D. TUBERCULIN REACTIVITY OF A CARBOHYDRATE COMPONENT OF UNHEATED BCG CULTURE FILTRATE. Science. 1964 Oct 9;146(3641):245–247. doi: 10.1126/science.146.3641.245. [DOI] [PubMed] [Google Scholar]
  2. Beecroft R. P., Roditi I., Pearson T. W. Identification and characterization of an acidic major surface glycoprotein from procyclic stage Trypanosoma congolense. Mol Biochem Parasitol. 1993 Oct;61(2):285–294. doi: 10.1016/0166-6851(93)90074-8. [DOI] [PubMed] [Google Scholar]
  3. Berman J. D., Dwyer D. M. Expression of Leishmania antigen on the surface membrane of infected human macrophages in vitro. Clin Exp Immunol. 1981 May;44(2):342–348. [PMC free article] [PubMed] [Google Scholar]
  4. Channon J. Y., Roberts M. B., Blackwell J. M. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages. Immunology. 1984 Oct;53(2):345–355. [PMC free article] [PubMed] [Google Scholar]
  5. Cunningham I. New culture medium for maintenance of tsetse tissues and growth of trypanosomatids. J Protozool. 1977 May;24(2):325–329. doi: 10.1111/j.1550-7408.1977.tb00987.x. [DOI] [PubMed] [Google Scholar]
  6. Domer J. E., Garner R. E., Befidi-Mengue R. N. Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI. Infect Immun. 1989 Mar;57(3):693–700. doi: 10.1128/iai.57.3.693-700.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dwyer D. M. Antibody-induced modulation of Leishmania donovani surface membrane antigens. J Immunol. 1976 Dec;117(6):2081–2091. [PubMed] [Google Scholar]
  8. Dwyer D. M. Leishmania donovani: surface membrane carbohydrates of promastigotes. Exp Parasitol. 1977 Apr;41(2):341–358. doi: 10.1016/0014-4894(77)90107-2. [DOI] [PubMed] [Google Scholar]
  9. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry. 1971 Sep;8(9):871–874. doi: 10.1016/0019-2791(71)90454-x. [DOI] [PubMed] [Google Scholar]
  10. Farah F. S., Samra S. A., Nuwayri-Salti N. The role of the macrophage in cutaneous leishmaniasis. Immunology. 1975 Oct;29(4):755–764. [PMC free article] [PubMed] [Google Scholar]
  11. Handman E., Ceredig R., Mitchell G. F. Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages. Aust J Exp Biol Med Sci. 1979 Feb;57(1):9–29. doi: 10.1038/icb.1979.2. [DOI] [PubMed] [Google Scholar]
  12. Handman E., Goding J. W. The Leishmania receptor for macrophages is a lipid-containing glycoconjugate. EMBO J. 1985 Feb;4(2):329–336. doi: 10.1002/j.1460-2075.1985.tb03633.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Handman E., Mitchell G. F. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. Proc Natl Acad Sci U S A. 1985 Sep;82(17):5910–5914. doi: 10.1073/pnas.82.17.5910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Handman E. Study of Leishmania major-infected macrophages by use of lipophosphoglycan-specific monoclonal antibodies. Infect Immun. 1990 Jul;58(7):2297–2302. doi: 10.1128/iai.58.7.2297-2302.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hill J. O., Awwad M., North R. J. Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania. J Exp Med. 1989 May 1;169(5):1819–1827. doi: 10.1084/jem.169.5.1819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jaffe C. L., Shor R., Trau H., Passwell J. H. Parasite antigens recognized by patients with cutaneous leishmaniasis. Clin Exp Immunol. 1990 Apr;80(1):77–82. doi: 10.1111/j.1365-2249.1990.tb06444.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jardim A., Alexander J., Teh H. S., Ou D., Olafson R. W. Immunoprotective Leishmania major synthetic T cell epitopes. J Exp Med. 1990 Aug 1;172(2):645–648. doi: 10.1084/jem.172.2.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jardim A., Tolson D. L., Turco S. J., Pearson T. W., Olafson R. W. The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex. J Immunol. 1991 Nov 15;147(10):3538–3544. [PubMed] [Google Scholar]
  19. King D. L., Turco S. J. A ricin agglutinin-resistant clone of Leishmania donovani deficient in lipophosphoglycan. Mol Biochem Parasitol. 1988 Apr;28(3):285–293. doi: 10.1016/0166-6851(88)90013-8. [DOI] [PubMed] [Google Scholar]
  20. Liew F. Y. Functional heterogeneity of CD4+ T cells in leishmaniasis. Immunol Today. 1989 Feb;10(2):40–45. doi: 10.1016/0167-5699(89)90302-2. [DOI] [PubMed] [Google Scholar]
  21. McNeely T. B., Tolson D. L., Pearson T. W., Turco S. J. Characterization of Leishmania donovani variant clones using anti-lipophosphoglycan monoclonal antibodies. Glycobiology. 1990 Sep;1(1):63–69. doi: 10.1093/glycob/1.1.63. [DOI] [PubMed] [Google Scholar]
  22. Mehra V., Brennan P. J., Rada E., Convit J., Bloom B. R. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature. 1984 Mar 8;308(5955):194–196. doi: 10.1038/308194a0. [DOI] [PubMed] [Google Scholar]
  23. Mendonça S. C., Russell D. G., Coutinho S. G. Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63). Clin Exp Immunol. 1991 Mar;83(3):472–478. doi: 10.1111/j.1365-2249.1991.tb05663.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mitchell G. F., Handman E. T-lymphocytes recognise Leishmania glycoconjugates. Parasitol Today. 1985 Aug;1(2):61–63. doi: 10.1016/0169-4758(85)90117-6. [DOI] [PubMed] [Google Scholar]
  25. Moll H., Mitchell G. F., McConville M. J., Handman E. Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major. Infect Immun. 1989 Nov;57(11):3349–3356. doi: 10.1128/iai.57.11.3349-3356.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Molloy A., Gaudernack G., Levis W. R., Cohn Z. A., Kaplan G. Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide. Proc Natl Acad Sci U S A. 1990 Feb;87(3):973–977. doi: 10.1073/pnas.87.3.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  28. Orlandi P. A., Jr, Turco S. J. Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan. J Biol Chem. 1987 Jul 25;262(21):10384–10391. [PubMed] [Google Scholar]
  29. Podzorski R. P., Gray G. R., Nelson R. D. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J Immunol. 1990 Jan 15;144(2):707–716. [PubMed] [Google Scholar]
  30. Powderly W. G., Pier G. B., Markham R. B. In vitro T cell-mediated killing of Pseudomonas aeruginosa. V. Generation of bactericidal T cells in nonresponder mice. J Immunol. 1987 Apr 1;138(7):2272–2277. [PubMed] [Google Scholar]
  31. Richardson J. P., Beecroft R. P., Tolson D. L., Liu M. K., Pearson T. W. Procyclin: an unusual immunodominant glycoprotein surface antigen from the procyclic stage of African trypanosomes. Mol Biochem Parasitol. 1988 Dec;31(3):203–216. doi: 10.1016/0166-6851(88)90150-8. [DOI] [PubMed] [Google Scholar]
  32. Robertsson J. A., Svenson S. B., Lindberg A. A. Salmonella typhimurium infection in calves: delayed specific skin reactions directed against the O-antigenic polysaccharide chain. Infect Immun. 1982 Aug;37(2):737–748. doi: 10.1128/iai.37.2.737-748.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Russo D. M., Turco S. J., Burns J. M., Jr, Reed S. G. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins. J Immunol. 1992 Jan 1;148(1):202–207. [PubMed] [Google Scholar]
  34. Shapiro M. E., Onderdonk A. B., Kasper D. L., Finberg R. W. Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med. 1982 Apr 1;155(4):1188–1197. doi: 10.1084/jem.155.4.1188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tolson D. L., Schnur L. F., Jardim A., Pearson T. W. Distribution of lipophosphoglycan-associated epitopes in different Leishmania species and in African trypanosomes. Parasitol Res. 1994;80(6):537–542. doi: 10.1007/BF00932704. [DOI] [PubMed] [Google Scholar]
  36. Tolson D. L., Turco S. J., Beecroft R. P., Pearson T. W. The immunochemical structure and surface arrangement of Leishmania donovani lipophosphoglycan determined using monoclonal antibodies. Mol Biochem Parasitol. 1989 Jun 15;35(2):109–118. doi: 10.1016/0166-6851(89)90113-8. [DOI] [PubMed] [Google Scholar]
  37. Tolson D. L., Turco S. J., Pearson T. W. Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani. Infect Immun. 1990 Nov;58(11):3500–3507. doi: 10.1128/iai.58.11.3500-3507.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Turco S. J., Hull S. R., Orlandi P. A., Jr, Shepherd S. D., Homans S. W., Dwek R. A., Rademacher T. W. Structure of the major carbohydrate fragment of the Leishmania donovani lipophosphoglycan. Biochemistry. 1987 Sep 22;26(19):6233–6238. doi: 10.1021/bi00393a042. [DOI] [PubMed] [Google Scholar]
  39. Turco S. J., Orlandi P. A., Jr, Homans S. W., Ferguson M. A., Dwek R. A., Rademacher T. W. Structure of the phosphosaccharide-inositol core of the Leishmania donovani lipophosphoglycan. J Biol Chem. 1989 Apr 25;264(12):6711–6715. [PubMed] [Google Scholar]
  40. Turco S. J. The leishmanial lipophosphoglycan: a multifunctional molecule. Exp Parasitol. 1990 Feb;70(2):241–245. doi: 10.1016/0014-4894(90)90105-l. [DOI] [PubMed] [Google Scholar]
  41. Turco S. J., Wilkerson M. A., Clawson D. R. Expression of an unusual acidic glycoconjugate in Leishmania donovani. J Biol Chem. 1984 Mar 25;259(6):3883–3889. [PubMed] [Google Scholar]
  42. Williams K. M., Sacci J. B., Anthony R. L. Identification and recovery of Leishmania antigen displayed on the surface membrane of mouse peritoneal macrophages infected in vitro. J Immunol. 1986 Mar 1;136(5):1853–1858. [PubMed] [Google Scholar]
  43. de Ibarra A. A., Howard J. G., Snary D. Monoclonal antibodies to Leishmania tropica major: specificities and antigen location. Parasitology. 1982 Dec;85(Pt 3):523–531. doi: 10.1017/s0031182000056304. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES